ATOVAQUONE ORAL SUSPENSION

ATOVAQUONE ORAL SUSPENSION was reported 6939 times

ATOVAQUONE ORAL SUSPENSION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CUTANEOUS EXTRAMEDULLARY HAEMOPOIESIS 4 0.6667
1 MYELODYSPLASTIC SYNDROME WITH MULTILINEAGE DYSPLASIA 13 0.2549
2 IVTH NERVE PARALYSIS 42 0.1772
3 PHALANGEAL HYPOPLASIA 12 0.1690
4 TRANSPLANT ABSCESS 6 0.1304
5 ENCEPHALITIS PROTOZOAL 7 0.1250
6 HAEMOPHILUS BACTERAEMIA 6 0.1224
7 CUTANEOUS MUCORMYCOSIS 21 0.1141
8 MENINGOENCEPHALITIS AMOEBIC 6 0.1034
9 CUTANEOUS MALACOPLAKIA 5 0.0980
10 ACANTHAMOEBA INFECTION 17 0.0904
11 HEPATIC AMOEBIASIS 6 0.0896
12 CAMPYLOBACTER TEST POSITIVE 6 0.0789
13 CUTANEOUS NOCARDIOSIS 9 0.0692
14 VOCAL CORD OPERATION 6 0.0638
15 MALACOPLAKIA 28 0.0611
16 DISSEMINATED TOXOPLASMOSIS 7 0.0583
17 PULMONARY NOCARDIOSIS 46 0.0558
18 SPONTANEOUS BACTERIAL PERITONITIS 12 0.0492
19 TOTAL LUNG CAPACITY INCREASED 13 0.0478
20 PHARYNGEAL CYST 5 0.0463
21 SCROTAL ULCER 11 0.0421
22 FUNGAL DISEASE CARRIER 4 0.0396
23 GASTROINTESTINAL TRACT MUCOSAL PIGMENTATION 10 0.0368
24 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 8 0.0362
25 NOCARDIOSIS 92 0.0359
26 CEREBELLAR STROKE 14 0.0358
27 CHEST WALL ABSCESS 7 0.0354
28 SUSPECTED DRUG-INDUCED LIVER INJURY 7 0.0350
29 MORGANELLA INFECTION 10 0.0341
30 PENILE ULCERATION 11 0.0336
31 DEVICE RELATED BACTERAEMIA 10 0.0323
32 ACUTE PULMONARY HISTOPLASMOSIS 5 0.0314
33 BURKHOLDERIA CEPACIA COMPLEX INFECTION 8 0.0280
34 CRYPTOCOCCAL FUNGAEMIA 4 0.0280
35 LEISHMANIASIS 8 0.0276
36 IGA NEPHROPATHY 45 0.0271
37 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 14 0.0268
38 CONGENITAL FOOT MALFORMATION 12 0.0264
39 CONGENITAL APLASIA 8 0.0257
40 PNEUMOCYSTIS JIROVECII INFECTION 25 0.0209
41 FUNGAL PHARYNGITIS 5 0.0199
42 ENTEROCOCCAL BACTERAEMIA 20 0.0189
43 CORNEAL INFECTION 4 0.0184
44 PROTEUS INFECTION 13 0.0181
45 HUMAN HERPESVIRUS 8 INFECTION 11 0.0181
46 ANAEMIA MEGALOBLASTIC 8 0.0179
47 DISSEMINATED MUCORMYCOSIS 7 0.0178
48 MONOCLONAL IMMUNOGLOBULIN INCREASED 5 0.0175
49 ARTERIOVENOUS FISTULA THROMBOSIS 6 0.0173
50 CENTRAL NERVOUS SYSTEM FUNGAL INFECTION 4 0.0172
51 FUSARIUM INFECTION 12 0.0171
52 CEREBRAL TOXOPLASMOSIS 16 0.0171
53 WOUND INFECTION BACTERIAL 7 0.0169
54 TOXOPLASMOSIS 18 0.0167
55 CHRONIC GRAFT VERSUS HOST DISEASE IN LIVER 6 0.0165
56 CHRONIC GRAFT VERSUS HOST DISEASE ORAL 4 0.0163
57 VASOGENIC CEREBRAL OEDEMA 11 0.0153
58 CHYLOTHORAX 11 0.0153
59 LUNG TRANSPLANT REJECTION 10 0.0152
60 PNEUMOCYSTIS JIROVECII PNEUMONIA 152 0.0151
61 GRAFT VERSUS HOST DISEASE IN LUNG 7 0.0146
62 EVANS SYNDROME 7 0.0142
63 CEREBRAL MASS EFFECT 5 0.0138
64 SYPHILIS 10 0.0138
65 MIXED LIVER INJURY 41 0.0136
66 GENERALISED BULLOUS FIXED DRUG ERUPTION 5 0.0134
67 DISSEMINATED CRYPTOCOCCOSIS 10 0.0132
68 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 12 0.0130
69 ANAL ULCER 10 0.0122
70 VULVAL DISORDER 8 0.0121
71 MUCORMYCOSIS 30 0.0115
72 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 57 0.0114
73 PULMONARY MUCORMYCOSIS 6 0.0114
74 DELAYED GRAFT FUNCTION 8 0.0113
75 JARISCH-HERXHEIMER REACTION 8 0.0112
76 MYCOBACTERIAL INFECTION 19 0.0110
77 ZYGOMYCOSIS 5 0.0107
78 ENTEROCOCCAL INFECTION 50 0.0103
79 MARROW HYPERPLASIA 7 0.0103
80 ENTEROCOCCAL SEPSIS 8 0.0099
81 MENINGITIS LISTERIA 5 0.0098
82 GENE MUTATION 19 0.0096
83 SYSTEMIC CANDIDA 24 0.0096
84 METHAEMOGLOBINAEMIA 22 0.0095
85 GRAFT VERSUS HOST DISEASE 67 0.0093
86 THROMBOTIC MICROANGIOPATHY 90 0.0092
87 LICHENOID KERATOSIS 21 0.0092
88 STAPHYLOCOCCAL SKIN INFECTION 11 0.0089
89 CYTOMEGALOVIRUS CHORIORETINITIS 17 0.0087
90 HEPATIC CYTOLYSIS 111 0.0087
91 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 51 0.0086
92 PARAINFLUENZAE VIRUS INFECTION 13 0.0085
93 INFECTIOUS PLEURAL EFFUSION 13 0.0085
94 CYTOMEGALOVIRUS TEST POSITIVE 15 0.0084
95 DERMO-HYPODERMITIS 5 0.0084
96 ENTEROBACTER INFECTION 14 0.0083
97 KLEBSIELLA INFECTION 40 0.0079
98 VOCAL CORD PARALYSIS 14 0.0078
99 INVASIVE LOBULAR BREAST CARCINOMA 4 0.0078
100 MUCOSAL DISCOLOURATION 5 0.0078
101 IMMUNE RECONSTITUTION SYNDROME 10 0.0077
102 KLEBSIELLA TEST POSITIVE 5 0.0077
103 CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN 7 0.0076
104 GASTROINTESTINAL INJURY 20 0.0074
105 PNEUMONIA FUNGAL 29 0.0073
106 CYTOMEGALOVIRUS VIRAEMIA 32 0.0072
107 HYPOMANIA 26 0.0071
108 GRAFT VERSUS HOST DISEASE IN SKIN 15 0.0068
109 STAPHYLOCOCCAL BACTERAEMIA 29 0.0067
110 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 50 0.0067
111 BICYTOPENIA 13 0.0066
112 FEBRILE BONE MARROW APLASIA 28 0.0066
113 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 14 0.0066
114 PNEUMONIA KLEBSIELLA 12 0.0065
115 URINARY TRACT INFECTION ENTEROCOCCAL 6 0.0064
116 HEPATOBILIARY DISEASE 4 0.0064
117 KLEBSIELLA BACTERAEMIA 6 0.0063
118 ASPERGILLUS INFECTION 41 0.0062
119 GLOMERULONEPHRITIS RAPIDLY PROGRESSIVE 7 0.0062
120 HISTOPLASMOSIS 11 0.0062
121 PNEUMONIA CYTOMEGALOVIRAL 12 0.0062
122 CYTOKINE RELEASE SYNDROME 119 0.0059
123 DEMYELINATING POLYNEUROPATHY 6 0.0058
124 PNEUMOCYSTIS JIROVECI PNEUMONIA 13 0.0058
125 GRANULOMATOSIS WITH POLYANGIITIS 7 0.0058
126 VIRAEMIA 8 0.0058
127 ANAEMIA MACROCYTIC 12 0.0056
128 MYCOBACTERIUM AVIUM COMPLEX INFECTION 15 0.0056
129 ESCHERICHIA BACTERAEMIA 13 0.0055
130 LISTERIOSIS 6 0.0054
131 JAUNDICE CHOLESTATIC 19 0.0054
132 VASCULAR PSEUDOANEURYSM 9 0.0052
133 AGRANULOCYTOSIS 96 0.0052
134 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 17 0.0051
135 IMMUNE-MEDIATED HEPATIC DISORDER 10 0.0051
136 HISTOPLASMOSIS DISSEMINATED 8 0.0050
137 BRONCHOPULMONARY ASPERGILLOSIS 39 0.0050
138 PNEUMOMEDIASTINUM 9 0.0050
139 LUNG OPACITY 13 0.0049
140 ORAL MUCOSA EROSION 6 0.0049
141 SPONTANEOUS HAEMORRHAGE 5 0.0049
142 STERNAL FRACTURE 6 0.0049
143 CORONAVIRUS TEST POSITIVE 5 0.0049
144 ADENOVIRUS INFECTION 14 0.0048
145 LUNG ABSCESS 10 0.0048
146 BRAIN ABSCESS 12 0.0047
147 STEROID DIABETES 7 0.0047
148 ORGANISING PNEUMONIA 23 0.0046
149 VANISHING BILE DUCT SYNDROME 5 0.0045
150 INFECTION REACTIVATION 5 0.0044
151 CENTRAL NERVOUS SYSTEM LYMPHOMA 6 0.0044
152 DYSLEXIA 5 0.0043
153 CYTOMEGALOVIRUS INFECTION REACTIVATION 19 0.0043
154 OPTIC NEUROPATHY 9 0.0042
155 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 6 0.0042
156 INTRACRANIAL MASS 4 0.0042
157 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 4 0.0042
158 BACTERAEMIA 50 0.0042
159 VARICELLA 10 0.0042
160 UPPER RESPIRATORY TRACT INFLAMMATION 5 0.0042
161 TOXIC EPIDERMAL NECROLYSIS 63 0.0041
162 CYTOPENIA 50 0.0041
163 HAEMOPHILUS INFECTION 4 0.0041
164 DACTYLITIS 4 0.0041
165 ENCEPHALOPATHY 99 0.0040
166 ESCHERICHIA INFECTION 33 0.0040
167 PERSECUTORY DELUSION 10 0.0040
168 MENINGITIS CRYPTOCOCCAL 7 0.0040
169 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 11 0.0040
170 RASH MORBILLIFORM 11 0.0040
171 HYPERBILIRUBINAEMIA 41 0.0040
172 IMMUNE-MEDIATED HEPATITIS 8 0.0039
173 CALCULUS URINARY 6 0.0039
174 HYPERURICAEMIA 16 0.0039
175 FUNGAEMIA 6 0.0038
176 PNEUMONIA BACTERIAL 35 0.0038
177 MYOPIA 9 0.0038
178 CRYPTOCOCCOSIS 6 0.0037
179 CYTOMEGALOVIRUS INFECTION 60 0.0036
180 VACCINATION FAILURE 6 0.0036
181 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 28 0.0036
182 BRAIN DEATH 11 0.0036
183 PNEUMONIA STAPHYLOCOCCAL 7 0.0035
184 ATYPICAL MYCOBACTERIAL INFECTION 5 0.0035
185 CATAPLEXY 5 0.0035
186 DIFFUSE LARGE B-CELL LYMPHOMA 27 0.0035
187 CORTISOL DECREASED 4 0.0035
188 POST HERPETIC NEURALGIA 5 0.0035
189 TONGUE COATED 6 0.0035
190 NOROVIRUS INFECTION 5 0.0035
191 DERMATITIS EXFOLIATIVE GENERALISED 12 0.0034
192 RESPIRATORY SYNCYTIAL VIRUS INFECTION 30 0.0034
193 SPLENIC INFARCTION 6 0.0034
194 EXTREMITY NECROSIS 6 0.0034
195 LIP ULCERATION 4 0.0034
196 PNEUMONIA PNEUMOCOCCAL 5 0.0034
197 RHINITIS ALLERGIC 15 0.0034
198 EPSTEIN-BARR VIRUS INFECTION 21 0.0034
199 PANCYTOPENIA 186 0.0033
200 RASH MACULO-PAPULAR 74 0.0033
201 SOFT TISSUE INFECTION 6 0.0033
202 BRONCHIECTASIS 22 0.0033
203 OESOPHAGEAL CANDIDIASIS 13 0.0033
204 ACUTE MYELOID LEUKAEMIA RECURRENT 7 0.0033
205 PNEUMONIA PSEUDOMONAL 5 0.0033
206 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
207 PARTIAL SEIZURES 17 0.0032
208 FEBRILE NEUTROPENIA 215 0.0032
209 BLOOD ELECTROLYTES ABNORMAL 4 0.0032
210 MYELITIS 5 0.0032
211 CHOLESTASIS 62 0.0032
212 VENOOCCLUSIVE DISEASE 8 0.0032
213 COMPLICATIONS OF TRANSPLANTED KIDNEY 7 0.0031
214 DRUG RESISTANCE 79 0.0031
215 READING DISORDER 7 0.0031
216 INTERCEPTED PRODUCT PRESCRIBING ERROR 4 0.0030
217 BK VIRUS INFECTION 10 0.0030
218 LEUKAEMIA RECURRENT 5 0.0030
219 SARCOIDOSIS 14 0.0029
220 KIDNEY TRANSPLANT REJECTION 14 0.0029
221 VARICELLA ZOSTER VIRUS INFECTION 6 0.0029
222 ACUTE MYELOID LEUKAEMIA 45 0.0029
223 SCHIZOPHRENIA 35 0.0029
224 PSEUDOMONAL SEPSIS 5 0.0029
225 BREAST DISCHARGE 5 0.0029
226 FANCONI SYNDROME ACQUIRED 5 0.0028
227 CULTURE URINE POSITIVE 4 0.0028
228 NASAL POLYPS 14 0.0028
229 RHINOVIRUS INFECTION 11 0.0028
230 GLOMERULAR FILTRATION RATE ABNORMAL 4 0.0028
231 URINARY TRACT INFECTION BACTERIAL 7 0.0028
232 RENAL TUBULAR ACIDOSIS 6 0.0027
233 TRANSPLANT REJECTION 22 0.0027
234 ENDOMETRIAL CANCER 6 0.0027
235 RETROPERITONEAL HAEMATOMA 6 0.0027
236 COVID-19 PNEUMONIA 32 0.0027
237 DRUG ERUPTION 48 0.0027
238 CHOLESTATIC LIVER INJURY 6 0.0027
239 DUODENAL ULCER 19 0.0027
240 PLASMACYTOMA 5 0.0027
241 PULMONARY ALVEOLAR HAEMORRHAGE 15 0.0027
242 SERUM FERRITIN INCREASED 14 0.0027
243 HYPERVOLAEMIA 13 0.0026
244 PROTEIN TOTAL INCREASED 7 0.0026
245 ACUTE GRAFT VERSUS HOST DISEASE 12 0.0026
246 SEPTIC SHOCK 114 0.0026
247 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 67 0.0026
248 ABSCESS LIMB 11 0.0026
249 PATHOGEN RESISTANCE 23 0.0025
250 RESPIRATORY FAILURE 184 0.0025
251 DRUG LEVEL INCREASED 41 0.0025
252 OESOPHAGITIS 27 0.0025
253 HAEMOLYSIS 19 0.0025
254 CLOSTRIDIUM DIFFICILE COLITIS 26 0.0024
255 HYPOGAMMAGLOBULINAEMIA 16 0.0024
256 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6 0.0024
257 VASCULAR DEVICE INFECTION 11 0.0024
258 LYME DISEASE 8 0.0024
259 HISTIOCYTOSIS HAEMATOPHAGIC 7 0.0024
260 B-CELL LYMPHOMA 8 0.0024
261 SHOCK HAEMORRHAGIC 19 0.0023
262 PHYSICAL DECONDITIONING 6 0.0023
263 PERICARDIAL HAEMORRHAGE 5 0.0023
264 INFECTION SUSCEPTIBILITY INCREASED 5 0.0023
265 ACUTE RESPIRATORY DISTRESS SYNDROME 40 0.0023
266 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 6 0.0023
267 LIVER TRANSPLANT REJECTION 4 0.0022
268 MULTIPLE ORGAN DYSFUNCTION SYNDROME 63 0.0022
269 PSEUDOMONAS INFECTION 19 0.0022
270 BLOOD HIV RNA INCREASED 4 0.0022
271 HEPATIC ENZYME ABNORMAL 11 0.0022
272 DISSEMINATED INTRAVASCULAR COAGULATION 31 0.0022
273 PNEUMONIA VIRAL 7 0.0022
274 ACUTE RESPIRATORY FAILURE 42 0.0022
275 HAEMOLYTIC URAEMIC SYNDROME 5 0.0022
276 PLASMA CELL MYELOMA RECURRENT 7 0.0022
277 THROMBOCYTOPENIA 239 0.0021
278 CANDIDA INFECTION 36 0.0021
279 FAILURE TO THRIVE 11 0.0021
280 HEPATOTOXICITY 47 0.0021
281 BONE MARROW TRANSPLANT 4 0.0021
282 LUNG NEOPLASM 9 0.0021
283 APLASTIC ANAEMIA 11 0.0021
284 RETINAL VEIN OCCLUSION 6 0.0021
285 AUTOIMMUNE HAEMOLYTIC ANAEMIA 7 0.0020
286 RENAL TUBULAR NECROSIS 20 0.0020
287 VENOOCCLUSIVE LIVER DISEASE 10 0.0020
288 BLOOD IMMUNOGLOBULIN G DECREASED 5 0.0020
289 EMPYEMA 4 0.0020
290 ATYPICAL PNEUMONIA 6 0.0020
291 STEM CELL TRANSPLANT 5 0.0020
292 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
293 MENINGITIS 13 0.0019
294 DIASTOLIC DYSFUNCTION 6 0.0019
295 CHRONIC GRAFT VERSUS HOST DISEASE 7 0.0019
296 IMMUNOSUPPRESSION 17 0.0019
297 COLITIS 73 0.0019
298 HAEMOLYTIC ANAEMIA 17 0.0019
299 GASTROINTESTINAL STROMAL TUMOUR 5 0.0019
300 CARDIAC DYSFUNCTION 7 0.0019
301 BONE MARROW FAILURE 38 0.0019
302 HYPERPHOSPHATAEMIA 4 0.0019
303 NEUTROPENIA 250 0.0018
304 SUBDURAL HAEMORRHAGE 5 0.0018
305 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 4 0.0018
306 LUNG INFILTRATION 16 0.0018
307 BACTERIAL TEST POSITIVE 4 0.0018
308 HEPATIC FUNCTION ABNORMAL 66 0.0018
309 HYPERKALAEMIA 62 0.0018
310 LYMPHOPENIA 25 0.0018
311 PNEUMATOSIS INTESTINALIS 5 0.0018
312 SKIN PAPILLOMA 7 0.0017
313 BLOOD BILIRUBIN INCREASED 47 0.0017
314 CYTOMEGALOVIRUS COLITIS 4 0.0017
315 CYSTITIS HAEMORRHAGIC 7 0.0017
316 BLOOD PRESSURE DIASTOLIC INCREASED 8 0.0017
317 RENAL FUNCTION TEST ABNORMAL 8 0.0017
318 GASTRITIS EROSIVE 8 0.0017
319 ANHEDONIA 45 0.0017
320 BILIRUBIN CONJUGATED INCREASED 4 0.0017
321 ERYTHEMA NODOSUM 6 0.0017
322 PAPULE 12 0.0017
323 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 14 0.0017
324 LUNG TRANSPLANT 6 0.0017
325 HERPES SIMPLEX 11 0.0017
326 RECALLED PRODUCT ADMINISTERED 16 0.0017
327 ODYNOPHAGIA 10 0.0017
328 ACUTE KIDNEY INJURY 256 0.0017
329 NEUTROPHIL COUNT DECREASED 68 0.0017
330 STEVENS-JOHNSON SYNDROME 37 0.0017
331 DIABETES INSIPIDUS 4 0.0017
332 HYPERCAPNIA 5 0.0017
333 BONE MARROW DISORDER 5 0.0017
334 OSTEOPENIA 25 0.0016
335 CUTANEOUS VASCULITIS 6 0.0016
336 HAEMATOLOGICAL INFECTION 4 0.0016
337 PORTAL HYPERTENSION 5 0.0016
338 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
339 CHOLELITHIASIS 53 0.0016
340 STAPHYLOCOCCAL INFECTION 53 0.0016
341 HYPERPARATHYROIDISM SECONDARY 4 0.0016
342 TUMOUR LYSIS SYNDROME 14 0.0016
343 DYSLIPIDAEMIA 8 0.0016
344 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 6 0.0016
345 ENTEROCOLITIS 9 0.0016
346 IRON DEFICIENCY 7 0.0016
347 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
348 RALES 9 0.0015
349 LIVER ABSCESS 5 0.0015
350 DRUG-INDUCED LIVER INJURY 48 0.0015
351 HYPERLIPIDAEMIA 18 0.0015
352 HYPOXIA 53 0.0015
353 CARDIAC MURMUR 13 0.0015
354 HYPOPHOSPHATAEMIA 11 0.0015
355 ANAL ABSCESS 8 0.0015
356 END STAGE RENAL DISEASE 27 0.0015
357 SEPSIS 165 0.0015
358 CHRONIC LYMPHOCYTIC LEUKAEMIA 7 0.0015
359 CHOLANGITIS 9 0.0015
360 HYPERTHERMIA 11 0.0014
361 NECROSIS 8 0.0014
362 PULMONARY TOXICITY 10 0.0014
363 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
364 ISCHAEMIC STROKE 25 0.0014
365 PNEUMONITIS 38 0.0014
366 RENAL TRANSPLANT 5 0.0014
367 LEUKOCYTOSIS 25 0.0014
368 LIVER TRANSPLANT 5 0.0014
369 RASH PUSTULAR 10 0.0014
370 AMYLASE INCREASED 5 0.0014
371 PLATELET COUNT DECREASED 144 0.0013
372 SKIN NECROSIS 7 0.0013
373 SKIN MASS 9 0.0013
374 NEPHROPATHY TOXIC 15 0.0013
375 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 73 0.0013
376 SUSPECTED OFF LABEL USE 6 0.0013
377 HIV INFECTION 4 0.0013
378 BLOOD LACTATE DEHYDROGENASE INCREASED 21 0.0013
379 PARANASAL SINUS DISCOMFORT 5 0.0013
380 ECONOMIC PROBLEM 20 0.0013
381 EOSINOPHILIA 23 0.0013
382 DISEASE COMPLICATION 6 0.0013
383 IMMUNE THROMBOCYTOPENIA 6 0.0013
384 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
385 INTERSTITIAL LUNG DISEASE 63 0.0013
386 OESOPHAGEAL ULCER 5 0.0013
387 LEUKOPENIA 65 0.0013
388 NEPHROGENIC ANAEMIA 6 0.0013
389 TOXIC SKIN ERUPTION 13 0.0013
390 DIARRHOEA HAEMORRHAGIC 12 0.0013
391 FAECALOMA 7 0.0013
392 HYPOCALCAEMIA 24 0.0013
393 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
394 SHOCK 29 0.0013
395 RED BLOOD CELL COUNT DECREASED 36 0.0013
396 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 12 0.0013
397 ALTERED STATE OF CONSCIOUSNESS 27 0.0012
398 INTERNATIONAL NORMALISED RATIO DECREASED 5 0.0012
399 HEPATITIS ACUTE 8 0.0012
400 INCORRECT DOSAGE ADMINISTERED 6 0.0012
401 ARTHRITIS BACTERIAL 5 0.0012
402 CEREBRAL DISORDER 9 0.0012
403 STAPHYLOCOCCAL SEPSIS 6 0.0012
404 METABOLIC DISORDER 7 0.0012
405 ELECTROLYTE IMBALANCE 14 0.0012
406 HYDRONEPHROSIS 9 0.0012
407 HEPATIC FAILURE 36 0.0012
408 FULL BLOOD COUNT DECREASED 24 0.0012
409 DRUG LEVEL DECREASED 12 0.0012
410 PLASMA CELL MYELOMA 46 0.0012
411 ENDOCARDITIS 6 0.0012
412 PLEURAL EFFUSION 71 0.0012
413 GASTROENTERITIS 17 0.0012
414 APHTHOUS ULCER 9 0.0012
415 AUTOIMMUNE HEPATITIS 8 0.0011
416 PULMONARY FUNCTION TEST DECREASED 5 0.0011
417 DEPRESSIVE SYMPTOM 4 0.0011
418 HYPOPHAGIA 29 0.0011
419 HEPATOCELLULAR INJURY 16 0.0011
420 MYELODYSPLASTIC SYNDROME 16 0.0011
421 SKIN LESION 30 0.0011
422 MOUTH ULCERATION 23 0.0011
423 ALANINE AMINOTRANSFERASE INCREASED 67 0.0011
424 ASCITES 32 0.0011
425 HAEMOGLOBIN ABNORMAL 7 0.0011
426 BLOOD PRESSURE DIASTOLIC DECREASED 8 0.0011
427 TRANSAMINASES INCREASED 24 0.0011
428 JAUNDICE 29 0.0011
429 LYMPHOCYTE COUNT DECREASED 19 0.0011
430 BACTERIAL INFECTION 20 0.0011
431 PYREXIA 367 0.0011
432 LIVER INJURY 26 0.0011
433 CATHETER SITE INFECTION 4 0.0011
434 BLOOD ALKALINE PHOSPHATASE INCREASED 26 0.0010
435 PYELONEPHRITIS 9 0.0010
436 LIVER DISORDER 46 0.0010
437 HYPOALBUMINAEMIA 8 0.0010
438 HYPOVOLAEMIA 6 0.0010
439 EPIGASTRIC DISCOMFORT 4 0.0010
440 PANCREATITIS ACUTE 23 0.0010
441 ENCEPHALITIS 7 0.0010
442 PNEUMONIA 326 0.0010
443 RENAL FAILURE 133 0.0010
444 COVID-19 175 0.0010
445 CANDIDIASIS 4 0.0010
446 HEPATITIS CHOLESTATIC 6 0.0010
447 PERICARDIAL EFFUSION 23 0.0010
448 RENAL IMPAIRMENT 83 0.0010
449 DERMATITIS ACNEIFORM 6 0.0010
450 DEVICE RELATED INFECTION 15 0.0010
451 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
452 CELLULITIS 48 0.0010
453 BLOOD LACTIC ACID INCREASED 5 0.0009
454 IMMUNODEFICIENCY 14 0.0009
455 ANAEMIA 179 0.0009
456 VIROLOGIC FAILURE 5 0.0009
457 GINGIVITIS 5 0.0009
458 BLOOD MAGNESIUM DECREASED 8 0.0009
459 STRESS FRACTURE 5 0.0009
460 MYOPATHY 8 0.0009
461 ASPARTATE AMINOTRANSFERASE INCREASED 49 0.0009
462 DRUG INTERACTION 146 0.0009
463 MUCOSAL INFLAMMATION 24 0.0009
464 HYPOKALAEMIA 42 0.0009
465 ADRENAL INSUFFICIENCY 11 0.0009
466 PURPURA 8 0.0009
467 STREPTOCOCCAL INFECTION 5 0.0009
468 LUNG DISORDER 44 0.0009
469 MALNUTRITION 10 0.0009
470 MYOSITIS 8 0.0009
471 ANAL INCONTINENCE 8 0.0009
472 BLOOD CREATININE INCREASED 58 0.0009
473 WHITE BLOOD CELL COUNT DECREASED 96 0.0009
474 REBOUND EFFECT 10 0.0009
475 DISEASE RECURRENCE 42 0.0009
476 BLOOD ALBUMIN DECREASED 7 0.0009
477 TREATMENT FAILURE 73 0.0009
478 UROSEPSIS 8 0.0009
479 BLOOD URIC ACID INCREASED 5 0.0009
480 HYPERTRANSAMINASAEMIA 6 0.0009
481 STRESS CARDIOMYOPATHY 5 0.0009
482 CONDITION AGGRAVATED 261 0.0009
483 ERYTHEMA MULTIFORME 8 0.0009
484 NEUROTOXICITY 15 0.0009
485 HYPERTRIGLYCERIDAEMIA 5 0.0009
486 FULL BLOOD COUNT ABNORMAL 9 0.0009
487 HYPERGLYCAEMIA 31 0.0008
488 OFF LABEL USE 742 0.0008
489 SPINAL COMPRESSION FRACTURE 7 0.0008
490 LYMPHOMA 13 0.0008
491 FUNGAL INFECTION 28 0.0008
492 LIVER FUNCTION TEST INCREASED 18 0.0008
493 HEPATIC ENZYME INCREASED 57 0.0008
494 HEPATITIS B 5 0.0008
495 DERMATITIS BULLOUS 6 0.0008
496 MENTAL STATUS CHANGES 23 0.0008
497 DYSPNOEA EXERTIONAL 31 0.0008
498 BLOOD PRESSURE SYSTOLIC INCREASED 16 0.0008
499 MELAENA 18 0.0008
500 HYPERCALCAEMIA 10 0.0008
501 TACHYPNOEA 11 0.0008
502 HYPERNATRAEMIA 4 0.0008
503 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
504 HYPERAMMONAEMIA 4 0.0008
505 INFUSION SITE SWELLING 5 0.0008
506 TASTE DISORDER 16 0.0008
507 DISEASE PROGRESSION 93 0.0008
508 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
509 MYOCARDITIS 9 0.0008
510 WHITE BLOOD CELL COUNT ABNORMAL 5 0.0008
511 HEPATITIS 20 0.0008
512 NEUTROPHIL COUNT INCREASED 8 0.0008
513 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
514 SPLENOMEGALY 9 0.0008
515 PETECHIAE 8 0.0008
516 TRANSFUSION 8 0.0008
517 ORAL CANDIDIASIS 10 0.0008
518 DYSGRAPHIA 5 0.0008
519 CORONAVIRUS INFECTION 5 0.0008
520 MULTI-ORGAN FAILURE 13 0.0008
521 PRESCRIBED UNDERDOSE 15 0.0008
522 CARDIAC FAILURE ACUTE 5 0.0007
523 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
524 QUALITY OF LIFE DECREASED 10 0.0007
525 LOCALISED INFECTION 18 0.0007
526 RHINITIS 6 0.0007
527 C-REACTIVE PROTEIN INCREASED 27 0.0007
528 LEUKAEMIA 7 0.0007
529 DECUBITUS ULCER 6 0.0007
530 HAEMATOMA 19 0.0007
531 GLOMERULAR FILTRATION RATE DECREASED 9 0.0007
532 MULTIPLE FRACTURES 12 0.0007
533 NEPHROTIC SYNDROME 5 0.0007
534 OSTEOPOROSIS 30 0.0007
535 ECCHYMOSIS 5 0.0007
536 BLOOD COUNT ABNORMAL 11 0.0007
537 RESPIRATORY DISTRESS 20 0.0007
538 GOUT 13 0.0007
539 ACUTE CORONARY SYNDROME 6 0.0007
540 RED BLOOD CELL SEDIMENTATION RATE INCREASED 8 0.0007
541 DIZZINESS POSTURAL 7 0.0007
542 HAEMOGLOBIN DECREASED 74 0.0007
543 HYPOMAGNESAEMIA 10 0.0007
544 OSTEOMYELITIS 13 0.0007
545 BLOOD UREA INCREASED 12 0.0007
546 HAEMODIALYSIS 6 0.0007
547 HERPES ZOSTER 41 0.0007
548 HEPATOMEGALY 7 0.0007
549 FACE OEDEMA 12 0.0007
550 SEASONAL ALLERGY 10 0.0007
551 DIALYSIS 10 0.0007
552 GENERALISED ERYTHEMA 4 0.0007
553 SKIN ULCER 18 0.0007
554 OXYGEN SATURATION DECREASED 39 0.0007
555 DEEP VEIN THROMBOSIS 45 0.0007
556 FEEDING DISORDER 14 0.0007
557 CHILLS 80 0.0007
558 MOUTH HAEMORRHAGE 5 0.0007
559 PNEUMONIA ASPIRATION 17 0.0007
560 TREATMENT NONCOMPLIANCE 37 0.0007
561 VENTRICULAR EXTRASYSTOLES 7 0.0007
562 PULMONARY MASS 10 0.0007
563 ACUTE HEPATIC FAILURE 9 0.0007
564 CHRONIC KIDNEY DISEASE 50 0.0007
565 HAEMODYNAMIC INSTABILITY 5 0.0007
566 HEPATIC STEATOSIS 12 0.0006
567 WOUND INFECTION 7 0.0006
568 BONE DENSITY DECREASED 20 0.0006
569 MUSCLE ATROPHY 8 0.0006
570 PNEUMOTHORAX 10 0.0006
571 SUBDURAL HAEMATOMA 9 0.0006
572 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
573 PULMONARY OEDEMA 28 0.0006
574 INTESTINAL PERFORATION 7 0.0006
575 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
576 LIVER FUNCTION TEST ABNORMAL 18 0.0006
577 MITRAL VALVE INCOMPETENCE 7 0.0006
578 ATRIAL FIBRILLATION 60 0.0006
579 RENAL FAILURE ACUTE 26 0.0006
580 MYELOSUPPRESSION 22 0.0006
581 PSYCHOTIC DISORDER 18 0.0006
582 HAEMATOCRIT DECREASED 12 0.0006
583 HAEMORRHAGE INTRACRANIAL 9 0.0006
584 VIRAL INFECTION 20 0.0006
585 SPINAL FRACTURE 12 0.0006
586 BRAIN INJURY 6 0.0006
587 PRODUCT USE IN UNAPPROVED INDICATION 148 0.0006
588 APHASIA 18 0.0006
589 COLITIS ISCHAEMIC 4 0.0006
590 SKIN PLAQUE 5 0.0006
591 INFECTION 84 0.0006
592 RENAL DISORDER 27 0.0006
593 LABORATORY TEST ABNORMAL 17 0.0006
594 LARGE INTESTINE PERFORATION 4 0.0006
595 METABOLIC ACIDOSIS 18 0.0006
596 STOMATITIS 34 0.0006
597 PARALYSIS 8 0.0006
598 DECREASED ACTIVITY 6 0.0006
599 LACTIC ACIDOSIS 18 0.0006
600 BLOOD POTASSIUM INCREASED 9 0.0006
601 ABDOMINAL PAIN LOWER 14 0.0006
602 SKIN LACERATION 6 0.0006
603 TACHYCARDIA 49 0.0006
604 HYPONATRAEMIA 31 0.0005
605 FAECES SOFT 4 0.0005
606 DIARRHOEA 355 0.0005
607 FLUID OVERLOAD 8 0.0005
608 ASPIRATION 6 0.0005
609 ACUTE MYOCARDIAL INFARCTION 16 0.0005
610 DIPLOPIA 14 0.0005
611 GASTROINTESTINAL HAEMORRHAGE 45 0.0005
612 NEUROPATHY PERIPHERAL 51 0.0005
613 DEAFNESS 14 0.0005
614 PRESYNCOPE 13 0.0005
615 FLANK PAIN 5 0.0005
616 BONE LOSS 8 0.0005
617 SQUAMOUS CELL CARCINOMA 5 0.0005
618 BLOOD SODIUM DECREASED 10 0.0005
619 FRACTURE 10 0.0005
620 PULMONARY HYPERTENSION 11 0.0005
621 SCAB 6 0.0005
622 RASH 229 0.0005
623 LIPASE INCREASED 4 0.0005
624 DECREASED APPETITE 121 0.0005
625 ATELECTASIS 5 0.0005
626 ATRIOVENTRICULAR BLOCK 4 0.0005
627 PRODUCT TASTE ABNORMAL 7 0.0005
628 OEDEMA PERIPHERAL 63 0.0005
629 VASCULITIS 6 0.0005
630 EJECTION FRACTION DECREASED 8 0.0005
631 INFUSION RELATED REACTION 34 0.0005
632 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 15 0.0005
633 GASTROINTESTINAL INFLAMMATION 4 0.0005
634 GENERAL PHYSICAL HEALTH DETERIORATION 59 0.0005
635 BODY TEMPERATURE DECREASED 5 0.0005
636 HOSPICE CARE 5 0.0005
637 CHOLECYSTITIS 6 0.0005
638 RESPIRATORY TRACT CONGESTION 8 0.0005
639 INABILITY TO AFFORD MEDICATION 5 0.0005
640 MYOCLONUS 6 0.0005
641 PREMATURE DELIVERY 8 0.0005
642 ATRIAL FLUTTER 4 0.0005
643 ELECTROCARDIOGRAM QT PROLONGED 18 0.0005
644 RESPIRATORY TRACT INFECTION 13 0.0005
645 OEDEMA 27 0.0005
646 WHITE BLOOD CELL COUNT INCREASED 19 0.0005
647 GASTRITIS 13 0.0005
648 SINUS TACHYCARDIA 7 0.0005
649 INTENTIONAL PRODUCT USE ISSUE 43 0.0005
650 BODY TEMPERATURE INCREASED 10 0.0005
651 COUGH 137 0.0005
652 CARDIOGENIC SHOCK 7 0.0005
653 GENERALISED OEDEMA 6 0.0005
654 PHARYNGITIS 6 0.0005
655 PRODUCTIVE COUGH 23 0.0005
656 EPISTAXIS 36 0.0005
657 EYE DISCHARGE 5 0.0005
658 DEPRESSED LEVEL OF CONSCIOUSNESS 19 0.0005
659 TENDERNESS 5 0.0005
660 PRODUCT ODOUR ABNORMAL 5 0.0005
661 DERMATITIS ALLERGIC 6 0.0005
662 BRAIN OEDEMA 6 0.0005
663 HYPOTENSION 94 0.0005
664 HAEMATURIA 16 0.0005
665 HAEMOPTYSIS 13 0.0005
666 INFUSION SITE PAIN 6 0.0005
667 BLOOD POTASSIUM DECREASED 14 0.0005
668 ANURIA 4 0.0005
669 INCORRECT PRODUCT ADMINISTRATION DURATION 10 0.0005
670 BLOOD PRESSURE FLUCTUATION 11 0.0005
671 INSURANCE ISSUE 7 0.0005
672 INTERNATIONAL NORMALISED RATIO INCREASED 13 0.0005
673 TOOTH INFECTION 6 0.0005
674 PANCREATITIS 24 0.0005
675 CONSTIPATION 99 0.0005
676 BLOOD PRESSURE ABNORMAL 9 0.0005
677 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 4 0.0005
678 CEREBRAL INFARCTION 11 0.0004
679 THERAPY PARTIAL RESPONDER 7 0.0004
680 SKIN INFECTION 5 0.0004
681 STATUS EPILEPTICUS 5 0.0004
682 UVEITIS 6 0.0004
683 VOMITING 207 0.0004
684 ABSCESS 7 0.0004
685 MICTURITION URGENCY 5 0.0004
686 CONTUSION 42 0.0004
687 SENSORY DISTURBANCE 7 0.0004
688 CARDIO-RESPIRATORY ARREST 18 0.0004
689 HOSPITALISATION 66 0.0004
690 HEPATIC ENCEPHALOPATHY 4 0.0004
691 HEART RATE DECREASED 15 0.0004
692 SPINAL PAIN 5 0.0004
693 OSTEONECROSIS 14 0.0004
694 DRUG INTOLERANCE 41 0.0004
695 BLOOD IRON DECREASED 5 0.0004
696 EMOTIONAL DISTRESS 51 0.0004
697 DYSPNOEA 238 0.0004
698 PRODUCT PRESCRIBING ERROR 10 0.0004
699 EAR INFECTION 11 0.0004
700 INFLAMMATORY BOWEL DISEASE 4 0.0004
701 INFLAMMATION 21 0.0004
702 CARDIOMEGALY 5 0.0004
703 ILEUS 5 0.0004
704 HAEMATOCHEZIA 22 0.0004
705 CARDIAC FAILURE 32 0.0004
706 NAUSEA 313 0.0004
707 DIABETES MELLITUS INADEQUATE CONTROL 7 0.0004
708 INFLUENZA 44 0.0004
709 DEHYDRATION 52 0.0004
710 RIB FRACTURE 8 0.0004
711 HYPERTENSION 82 0.0004
712 BLOOD PRESSURE INCREASED 59 0.0004
713 RHABDOMYOLYSIS 16 0.0004
714 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 20 0.0004
715 BRAIN FOG 6 0.0004
716 FOLLICULITIS 4 0.0004
717 GASTROINTESTINAL DISORDER 34 0.0004
718 ANKYLOSING SPONDYLITIS 5 0.0004
719 BRONCHITIS 28 0.0004
720 THERAPY NON-RESPONDER 17 0.0004
721 DYSSTASIA 11 0.0004
722 RASH ERYTHEMATOUS 18 0.0004
723 MIDDLE INSOMNIA 7 0.0004
724 DELIRIUM 13 0.0004
725 NEPHROLITHIASIS 17 0.0004
726 SINUS CONGESTION 5 0.0004
727 SKIN DISCOLOURATION 17 0.0004
728 FAECES DISCOLOURED 8 0.0004
729 BLOOD URINE PRESENT 7 0.0004
730 PULMONARY EMBOLISM 35 0.0004
731 BACK INJURY 4 0.0004
732 TOXICITY TO VARIOUS AGENTS 62 0.0004
733 BLOOD GLUCOSE FLUCTUATION 4 0.0004
734 CARDIAC ARREST 30 0.0004
735 VISUAL ACUITY REDUCED 12 0.0004
736 DRY EYE 18 0.0004
737 COAGULOPATHY 6 0.0004
738 ASTHENIA 135 0.0004
739 DYSPHAGIA 34 0.0004
740 KIDNEY INFECTION 7 0.0004
741 BLOOD TEST ABNORMAL 5 0.0004
742 SKIN REACTION 5 0.0004
743 EYE INFECTION 4 0.0004
744 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 17 0.0004
745 FLUID RETENTION 18 0.0004
746 PRODUCT AVAILABILITY ISSUE 8 0.0004
747 THERAPY CESSATION 18 0.0004
748 INTERNAL HAEMORRHAGE 4 0.0003
749 PARANOIA 6 0.0003
750 MATERNAL EXPOSURE DURING PREGNANCY 31 0.0003
751 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
752 URINARY TRACT INFECTION 59 0.0003
753 ORTHOSTATIC HYPOTENSION 6 0.0003
754 FOETAL EXPOSURE DURING PREGNANCY 28 0.0003
755 HEART RATE INCREASED 34 0.0003
756 BONE PAIN 20 0.0003
757 CONFUSIONAL STATE 55 0.0003
758 CARDIOMYOPATHY 5 0.0003
759 OROPHARYNGEAL PAIN 31 0.0003
760 URINARY RETENTION 11 0.0003
761 CHEST PAIN 61 0.0003
762 EPILEPSY 10 0.0003
763 SKIN CANCER 7 0.0003
764 DYSPHONIA 19 0.0003
765 DIVERTICULITIS 9 0.0003
766 AMNESIA 21 0.0003
767 ABDOMINAL PAIN 75 0.0003
768 LUNG INFECTION 5 0.0003
769 PRODUCT PRESCRIBING ISSUE 7 0.0003
770 TUBULOINTERSTITIAL NEPHRITIS 6 0.0003
771 FOOT FRACTURE 6 0.0003
772 LUNG NEOPLASM MALIGNANT 13 0.0003
773 LOWER LIMB FRACTURE 6 0.0003
774 WEIGHT DECREASED 87 0.0003
775 NIGHT SWEATS 10 0.0003
776 ABDOMINAL DISCOMFORT 52 0.0003
777 RHINORRHOEA 20 0.0003
778 MUSCULAR WEAKNESS 35 0.0003
779 ORAL HERPES 6 0.0003
780 CEREBRAL HAEMORRHAGE 11 0.0003
781 PERIPHERAL SWELLING 47 0.0003
782 URINARY INCONTINENCE 9 0.0003
783 RECTAL HAEMORRHAGE 13 0.0003
784 DIABETES MELLITUS 23 0.0003
785 RESTLESSNESS 11 0.0003
786 GASTROOESOPHAGEAL REFLUX DISEASE 24 0.0003
787 DRUG INEFFECTIVE 392 0.0003
788 TYPE 2 DIABETES MELLITUS 10 0.0003
789 GINGIVAL BLEEDING 4 0.0003
790 ILLNESS 30 0.0003
791 FATIGUE 225 0.0003
792 HYPOGLYCAEMIA 14 0.0003
793 POLLAKIURIA 12 0.0003
794 PRODUCT USE ISSUE 54 0.0003
795 HUNGER 4 0.0003
796 HALLUCINATION, VISUAL 6 0.0003
797 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
798 CYSTITIS 9 0.0003
799 LYMPHADENOPATHY 10 0.0003
800 GALLBLADDER DISORDER 5 0.0003
801 DEATH 241 0.0003
802 ABDOMINAL DISTENSION 29 0.0003
803 DISORIENTATION 11 0.0003
804 GASTROENTERITIS VIRAL 5 0.0003
805 VISION BLURRED 38 0.0003
806 VAGINAL HAEMORRHAGE 12 0.0003
807 HYPERTHYROIDISM 4 0.0003
808 HAEMATEMESIS 7 0.0003
809 BONE DISORDER 5 0.0003
810 BACK PAIN 63 0.0003
811 BLOOD GLUCOSE ABNORMAL 5 0.0003
812 SKIN DISORDER 9 0.0003
813 WHEEZING 16 0.0003
814 DYSGEUSIA 20 0.0003
815 COLITIS ULCERATIVE 12 0.0003
816 ORAL PAIN 6 0.0003
817 THROAT IRRITATION 12 0.0003
818 SWELLING 25 0.0003
819 BLISTER 15 0.0003
820 ANXIETY 76 0.0003
821 THERAPY INTERRUPTED 19 0.0003
822 DYSARTHRIA 10 0.0003
823 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
824 THERAPEUTIC RESPONSE DECREASED 16 0.0003
825 ABDOMINAL PAIN UPPER 54 0.0003
826 LETHARGY 15 0.0003
827 DRY MOUTH 21 0.0003
828 LIMB INJURY 7 0.0003
829 HAEMORRHOIDS 5 0.0003
830 PALPITATIONS 30 0.0003
831 NASAL CONGESTION 15 0.0003
832 CYANOSIS 4 0.0003
833 CHEST DISCOMFORT 26 0.0003
834 CATARACT 15 0.0003
835 PRODUCT DOSE OMISSION ISSUE 74 0.0003
836 SEIZURE 29 0.0003
837 UPPER LIMB FRACTURE 5 0.0003
838 HIP FRACTURE 8 0.0002
839 PRODUCT PHYSICAL ISSUE 5 0.0002
840 NEURALGIA 6 0.0002
841 HYPERSOMNIA 7 0.0002
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
843 BALANCE DISORDER 21 0.0002
844 OSTEONECROSIS OF JAW 6 0.0002
845 TOOTH LOSS 5 0.0002
846 AGEUSIA 6 0.0002
847 RASH PRURITIC 13 0.0002
848 GAIT DISTURBANCE 45 0.0002
849 EATING DISORDER 5 0.0002
850 MALIGNANT NEOPLASM PROGRESSION 24 0.0002
851 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 4 0.0002
852 HEADACHE 146 0.0002
853 ANAPHYLACTIC SHOCK 6 0.0002
854 UNRESPONSIVE TO STIMULI 6 0.0002
855 RASH MACULAR 8 0.0002
856 PRURITUS 87 0.0002
857 BRADYCARDIA 12 0.0002
858 FEMUR FRACTURE 7 0.0002
859 BLOOD PRESSURE DECREASED 15 0.0002
860 EXPOSURE DURING PREGNANCY 14 0.0002
861 TOOTH DISORDER 5 0.0002
862 NERVOUS SYSTEM DISORDER 7 0.0002
863 THROMBOSIS 18 0.0002
864 TREMOR 37 0.0002
865 CHROMATURIA 5 0.0002
866 PAIN 136 0.0002
867 HYPOTHYROIDISM 7 0.0002
868 ERYTHEMA 45 0.0002
869 INFLUENZA LIKE ILLNESS 18 0.0002
870 JOINT SWELLING 26 0.0002
871 SINUSITIS 22 0.0002
872 BLOOD CHOLESTEROL INCREASED 10 0.0002
873 INSOMNIA 57 0.0002
874 BURNING SENSATION 15 0.0002
875 EYE PAIN 12 0.0002
876 HALLUCINATION 16 0.0002
877 INTESTINAL OBSTRUCTION 8 0.0002
878 PAIN IN JAW 6 0.0002
879 ECZEMA 11 0.0002
880 LIP SWELLING 7 0.0002
881 WEIGHT INCREASED 47 0.0002
882 ERUCTATION 4 0.0002
883 ADVERSE EVENT 19 0.0002
884 HYPERSENSITIVITY 38 0.0002
885 MUSCLE SPASMS 37 0.0002
886 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 36 0.0002
887 ANAPHYLACTIC REACTION 11 0.0002
888 DIZZINESS 99 0.0002
889 BLINDNESS 8 0.0002
890 TINNITUS 9 0.0002
891 MALAISE 85 0.0002
892 PANIC ATTACK 7 0.0002
893 ACCIDENTAL OVERDOSE 7 0.0002
894 URTICARIA 32 0.0002
895 DERMATITIS 4 0.0002
896 SPEECH DISORDER 10 0.0002
897 EYE SWELLING 7 0.0002
898 IMPAIRED WORK ABILITY 4 0.0002
899 CARDIAC FAILURE CONGESTIVE 15 0.0002
900 THROAT TIGHTNESS 5 0.0002
901 SWELLING FACE 12 0.0002
902 PRODUCT DOSE OMISSION 12 0.0002
903 FALL 61 0.0002
904 PAIN IN EXTREMITY 54 0.0002
905 DYSPEPSIA 18 0.0002
906 NECK PAIN 10 0.0002
907 WOUND 5 0.0002
908 EYE PRURITUS 6 0.0002
909 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
910 NASOPHARYNGITIS 32 0.0002
911 UNEVALUABLE EVENT 13 0.0002
912 COGNITIVE DISORDER 8 0.0002
913 MYALGIA 29 0.0002
914 SYNCOPE 17 0.0002
915 RENAL INJURY 5 0.0002
916 RESPIRATORY DISORDER 5 0.0002
917 HYPOAESTHESIA 25 0.0002
918 PREMATURE BABY 5 0.0002
919 OSTEOARTHRITIS 7 0.0002
920 VERTIGO 10 0.0002
921 ARTHRALGIA 67 0.0002
922 MENTAL DISORDER 7 0.0002
923 SOMNOLENCE 32 0.0002
924 LOSS OF CONSCIOUSNESS 20 0.0002
925 MOVEMENT DISORDER 5 0.0002
926 MUSCULOSKELETAL PAIN 8 0.0002
927 JOINT STIFFNESS 4 0.0002
928 NEOPLASM MALIGNANT 10 0.0001
929 ABNORMAL DREAMS 4 0.0001
930 FEELING COLD 4 0.0001
931 DRY SKIN 19 0.0001
932 SKIN EXFOLIATION 12 0.0001
933 SLEEP DISORDER 10 0.0001
934 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 10 0.0001
935 ARTHRITIS 11 0.0001
936 HYPERHIDROSIS 18 0.0001
937 UNDERDOSE 10 0.0001
938 DYSURIA 5 0.0001
939 ANGIOEDEMA 6 0.0001
940 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
941 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
942 DEPRESSION 30 0.0001
943 ILL-DEFINED DISORDER 8 0.0001
944 DISCOMFORT 8 0.0001
945 FEELING HOT 8 0.0001
946 VISUAL IMPAIRMENT 16 0.0001
947 ARRHYTHMIA 6 0.0001
948 OCULAR HYPERAEMIA 6 0.0001
949 COMA 6 0.0001
950 CEREBROVASCULAR ACCIDENT 21 0.0001
951 AGITATION 9 0.0001
952 PRODUCT SUBSTITUTION ISSUE 7 0.0001
953 PARAESTHESIA 19 0.0001
954 ROAD TRAFFIC ACCIDENT 5 0.0001
955 ACNE 9 0.0001
956 GASTRIC DISORDER 4 0.0001
957 MEMORY IMPAIRMENT 16 0.0001
958 IRRITABILITY 7 0.0001
959 NERVOUSNESS 6 0.0001
960 ADVERSE DRUG REACTION 10 0.0001
961 DISTURBANCE IN ATTENTION 6 0.0001
962 CRYING 4 0.0001
963 INCORRECT DOSE ADMINISTERED 25 0.0001
964 MYOCARDIAL INFARCTION 19 0.0001
965 ARTHROPATHY 6 0.0001
966 CARDIAC DISORDER 10 0.0001
967 HAEMORRHAGE 11 0.0001
968 CONVULSION 6 0.0001
969 SURGERY 6 0.0001
970 ASTHMA 11 0.0001
971 FEELING ABNORMAL 23 0.0001
972 DERMATITIS ATOPIC 5 0.0001
973 HYPOACUSIS 4 0.0001
974 PRODUCT STORAGE ERROR 8 0.0001
975 BLOOD GLUCOSE INCREASED 17 0.0001
976 MEDICATION ERROR 5 0.0001
977 NO ADVERSE EVENT 16 0.0001
978 FLATULENCE 5 0.0001
979 MOBILITY DECREASED 6 0.0001
980 ALOPECIA 14 0.0001
981 OVERDOSE 15 0.0001
982 DRUG DOSE OMISSION 11 0.0001
983 MIGRAINE 6 0.0001
984 INJECTION SITE PRURITUS 4 0.0001
985 FLUSHING 6 0.0001
986 INTENTIONAL PRODUCT MISUSE 5 0.0001
987 INJURY 4 0.0001
988 SUICIDAL IDEATION 5 0.0001
989 RHEUMATOID ARTHRITIS 6 0.0001
990 INJECTION SITE HAEMORRHAGE 4 0.0001
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 10 0.0000
992 INJECTION SITE ERYTHEMA 6 0.0000
993 INJECTION SITE PAIN 14 0.0000